Inhibition of the allergic response by regulatory T cells

Curr Opin Allergy Clin Immunol. 2006 Feb;6(1):12-6. doi: 10.1097/01.all.0000200502.69672.44.

Abstract

Purpose of review: Allergic diseases are caused by the overdevelopment of T-helper type 2 biased immune responses in susceptible individuals. A number of recent studies indicate that regulatory T cells play an important role in controlling such T-helper type 2 biased responses not only in animal models, but in humans as well, and these will be reviewed in this article.

Recent findings: A family of regulatory cells appears to be involved in regulating allergies. Both naturally occurring CD4CD25 regulatory T cells and inducible forms of antigen-specific regulatory T cells, both expressing the transcription factor foxp3, have been shown to inhibit the inappropriate immune responses involved in allergic diseases. Impaired expansion of natural or adaptive regulatory T cells is hypothesized to lead to the development of allergy, and treatment to induce allergen-specific regulatory T cells could provide curative therapies for allergy and asthma.

Summary: Allergen-specific regulatory T cells play an important role in controlling the development of allergy and asthma.

Publication types

  • Review

MeSH terms

  • Allergens / immunology
  • Epitopes
  • Humans
  • Hypersensitivity / immunology
  • Hypersensitivity / prevention & control*
  • Hypersensitivity / therapy
  • Immunotherapy
  • Interleukin-10 / immunology
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocytes, Regulatory / immunology*

Substances

  • Allergens
  • Epitopes
  • Interleukin-10